[go: up one dir, main page]

FI956074A0 - 1-Substituted isatin and oxindole derivatives acting as acetylcholinesterase inhibitors - Google Patents

1-Substituted isatin and oxindole derivatives acting as acetylcholinesterase inhibitors

Info

Publication number
FI956074A0
FI956074A0 FI956074A FI956074A FI956074A0 FI 956074 A0 FI956074 A0 FI 956074A0 FI 956074 A FI956074 A FI 956074A FI 956074 A FI956074 A FI 956074A FI 956074 A0 FI956074 A0 FI 956074A0
Authority
FI
Finland
Prior art keywords
acetylcholinesterase inhibitors
oxindole derivatives
substituted isatin
derivatives acting
acting
Prior art date
Application number
FI956074A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI956074A7 (en
Inventor
Bernard Robin Boar
Dennis Mark O'shea
Ian David Tomlinson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI956074A0 publication Critical patent/FI956074A0/en
Publication of FI956074A7 publication Critical patent/FI956074A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI956074A 1993-06-16 1995-12-18 1-substituted isatin and oxindole derivatives that act as acetylcholinesterase inhibitors FI956074A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302080A SE9302080D0 (en) 1993-06-16 1993-06-16 NEW COMPOUNDS
PCT/SE1994/000448 WO1994029272A1 (en) 1993-06-16 1994-05-13 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase

Publications (2)

Publication Number Publication Date
FI956074A0 true FI956074A0 (en) 1995-12-18
FI956074A7 FI956074A7 (en) 1995-12-18

Family

ID=20390305

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956074A FI956074A7 (en) 1993-06-16 1995-12-18 1-substituted isatin and oxindole derivatives that act as acetylcholinesterase inhibitors

Country Status (9)

Country Link
EP (1) EP0703901A1 (en)
JP (1) JPH08511515A (en)
AU (1) AU7010894A (en)
CA (1) CA2164119A1 (en)
FI (1) FI956074A7 (en)
IS (1) IS4167A (en)
NO (1) NO955074L (en)
SE (1) SE9302080D0 (en)
WO (1) WO1994029272A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103752D0 (en) * 1991-12-18 1991-12-18 Astra Ab NEW COMPOUNDS
NZ506217A (en) * 1998-03-06 2002-05-31 Astra Ab Compound for treatment of tuberculosis and other mycobacterial diseases
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
KR100648869B1 (en) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 Bladder Discharge Improvers
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
ES2332597T3 (en) * 2004-05-27 2010-02-09 Ucb Pharma S.A. DERIVATIVES OF BENZOXAZOLONA, PROCEDURES FOR THEIR PREPARATION AND USE.
US7632856B2 (en) 2004-07-22 2009-12-15 Ucb Pharma, S.A. Indolone derivatives, processes for preparing them and their uses
GT200500185A (en) 2004-08-09 2006-04-10 PROGESTERONE RECEIVER MODULATORS UNDERSTANDING PIRROL-OXINDOL DERIVATIVES AND THEIR USES
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
MY171802A (en) 2012-12-13 2019-10-30 H Lundbeck As Compositions comprising vortioxetine and donepezil
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
ES2881081T3 (en) 2013-03-15 2021-11-26 Agenebio Inc Procedures and compositions to improve cognitive function
CN103242332B (en) * 2013-05-13 2015-11-04 江西科技师范大学 1-N acyl substituted indolone derivatives
CN104530065A (en) * 2013-05-13 2015-04-22 江西科技师范大学 1-N acyl substituent indolone derivative application
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491106A (en) * 1964-06-11 1970-05-31 Ciba Geigy Process for the production of new thiosemicarbazones

Also Published As

Publication number Publication date
JPH08511515A (en) 1996-12-03
CA2164119A1 (en) 1994-12-22
FI956074A7 (en) 1995-12-18
NO955074L (en) 1996-02-07
IS4167A (en) 1994-12-17
WO1994029272A1 (en) 1994-12-22
EP0703901A1 (en) 1996-04-03
SE9302080D0 (en) 1993-06-16
NO955074D0 (en) 1995-12-14
AU7010894A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
FI956074A0 (en) 1-Substituted isatin and oxindole derivatives acting as acetylcholinesterase inhibitors
FI974436A0 (en) Substituted N- (indole-2-carbonyl) -glycinamides and derivatives as glycogen phosphorylase inhibitors
FI950859A7 (en) Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
FI944969A7 (en) Indole derivatives
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
NO301879B1 (en) Indole derivatives
GB9921054D0 (en) Indole and indoline derivatives as 5-ht6-selective ligands
DE69723446D1 (en) OXINDOLE DERIVATIVES
NZ299693A (en) 1,4-dioxino derivatives of indole and quinoline; pharmaceutical compositions
IL136954A0 (en) Indole derivatives as inhibitors of factor xa
FI954734A7 (en) Indole derivatives as 5HT1A and/or 5-HT2 ligands
ZA9711376B (en) Indole or dihydroindole derivatives
FI931558A7 (en) Indole derivatives
EP0707581A1 (en) Indoline derivatives as 5ht 2c? antagonists
NO961475D0 (en) Indole derivatives
DE69707659D1 (en) ISATINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS AND ANALGETICS
FI950568A7 (en) 5-Heteroaryl indole derivatives
PL341318A1 (en) Derivatives of indole useful in treating oesteoporosis
GB9420287D0 (en) 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase
FI960730A7 (en) Indole derivatives as 5alpha-reductase-1 inhibitors
IL119844A (en) Substituted indole derivatives and pharmaceutical compositions containing them
DK0725061T3 (en) Substituted indole derivatives
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
FI982654A0 (en) Nervous protective indolone and closely related derivatives
DE59605373D1 (en) Substituted indole derivatives

Legal Events

Date Code Title Description
FD Application lapsed